Proteomic patterns to identify ovarian cancer: 3 years on '... no testing, regardless of how sophisticated or technologically advanced, should be offered to patients without thorough clinical validation.'
No takes yet. Share an insight, caveat, or question.
Eleftherios P. Diamandis (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: